Document Detail


Serum Albumin Levels on Admission Are Associated With Angiographic No-Reflow After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
MedLine Citation:
PMID:  24650948     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Low serum albumin (SA) levels are associated with increased cardiovascular mortality. We investigated whether baseline SA levels are associated with no-reflow following primary percutaneous coronary intervention (pPCI). A total of 536 patients (aged 60 ± 13 years; 74% men) who underwent pPCI were enrolled. The patients were divided into 2 groups: no-reflow and normal-reflow. No-reflow was defined as thrombolysis in myocardial infarction ≤2 flow. Admission SA levels were significantly lower in the no-reflow group than in the normal-reflow group (3.55 ± 0.44 vs 4.01 ± 0.32 mg/dL, P < .001). Also, high-sensitivity C-reactive protein (hsCRP), creatinine, creatine kinase myocardial band isoenzyme, and troponin T were significantly higher while hemoglobin and left ventricular ejection fraction (LVEF) were significantly lower in the no-reflow group. In multivariate analysis, SA level remained an independent predictor of angiographic no-reflow (odds ratio 0.114, 95% confidence interval 0.032-0.405, P = .001) together with LVEF, hsCRP, and baseline culprit artery patency. Admission SA level was an independent predictor of no-reflow after pPCI.
Authors:
Alparslan Kurtul; Adil Hakan Ocek; Sani Namik Murat; Mikail Yarlioglues; Muhammed Bora Demircelik; Mustafa Duran; Gokhan Ergun; Serkan Cay
Related Documents :
23028178 - Mean platelet volume and extent and complexity of coronary artery disease in diabetic a...
24903988 - Streptomycin inhibits electrophysiological changes induced by stretching of chronically...
16242798 - Analysis of the extension of q-waves after infarction with body surface map: relationsh...
16164198 - Scintigraphic evaluation of regression of abnormal q waves in myocardial infarction.
1520248 - Allopurinol-enhanced myocardial protection does not involve xanthine oxidase inhibition...
1456878 - Hemostasis and cardiovascular risk. the british and european experience.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-3-19
Journal Detail:
Title:  Angiology     Volume:  -     ISSN:  1940-1574     ISO Abbreviation:  Angiology     Publication Date:  2014 Mar 
Date Detail:
Created Date:  2014-3-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0203706     Medline TA:  Angiology     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  School sun-protection policies--does being SunSmart make a difference?
Next Document:  Patterns of Disease Distribution of Lower Extremity Peripheral Arterial Disease.